Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1/2 1

Status

Completed 17Unknown 4Terminated 4Recruiting 4Not yet recruiting 2Active not recruiting 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 33Pancreatic Neoplasms 14Neuroblastoma 13Neoplasm Metastasis 10Stomach Neoplasms 9Neoplasms 8Rectal Neoplasms 5Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Ovarian Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Wilms Tumor 2Sarcoma 2Recurrence 2Osteosarcoma 2Gastrointestinal Neoplasms 2Ganglioneuroblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Solid Tumors 1

Interventions

Cisplatin 20Radiotherapy 16Paclitaxel 14Carboplatin 12pembrolizumab 11Drug Therapy 11tislelizumab 10Fluorouracil 8Neoadjuvant Therapy 7130-nm albumin-bound paclitaxel 7sintilimab 5Esophagectomy 5toripalimab 4Tegafur 4TP protocol 4Nivolumab 4Irinotecan 4Immunotherapy 4spartalizumab 3S 1 (combination) 3Oxaliplatin 3Leucovorin 3Itraconazole 3Docetaxel 3Albumin-Bound Paclitaxel 3nimotuzumab 2apatinib 2Taxes 2Radiotherapy, Intensity-Modulated 2Immune Checkpoint Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Esophageal Squamous Cell Carcinoma × Irinotecan × Clear all
NCT05319730 2026-05-26

MK-3475-06B

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting
230 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07463573 2026-04-24

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
466 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06644781 2026-01-12

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Daiichi Sankyo

Phase 3 Recruiting
510 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06194734 2024-03-07

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Beijing Konruns Pharmaceutical Co., Ltd.

Phase 3 Recruiting
490 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡